Alp Invest Partners B.V. Graybug Vision, Inc. Transaction History

Alp Invest Partners B.V.

  • $140 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$3.53 - $6.1 $647,507 - $1.12 Million
-183,430 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$5.55 - $35.0 $1.02 Million - $6.42 Million
183,430 New
183,430 $1.02 Million

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About GRAYBUG VISION, INC.

GRAY Quotes by TradingView
  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track This Portfolio

Track Alp Invest Partners B.V. Portfolio

Follow Alp Invest Partners B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alp Invest Partners B.V., based on Form 13F filings with the SEC.

News

Stay updated on Alp Invest Partners B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email